$EQ·8-K

Equillium, Inc. · May 29, 4:05 PM ET

Compare

Equillium, Inc. 8-K

Research Summary

AI-generated summary

Updated

Equillium, Inc. Reports 2026 Annual Meeting Results; Reverse Split Approved

What Happened

  • Equillium, Inc. (EQ) held its 2026 Annual Meeting of Stockholders on May 28, 2026 and filed an 8-K reporting the results. As of the April 1, 2026 record date, 63,226,556 shares were outstanding; 54,287,329 shares (≈85.86%) were present or represented by proxy.
  • Stockholders approved an amendment to authorize a reverse stock split of common stock at a ratio between 1-for-2 and 1-for-20, to be implemented at the Board’s discretion. They also approved an amendment to increase authorized common shares from 200,000,000 to 400,000,000 and ratified Crowe LLP as the company’s independent registered public accounting firm for fiscal 2026.
  • Two Class II directors were elected to serve until the 2029 annual meeting: Charles McDermott and Bruce Steel. Former director Peter Colabuono was not renominated and the Board size was reduced from seven to six directors.

Key Details

  • Record date/outstanding shares: April 1, 2026 — 63,226,556 shares; Shares present/represented: 54,287,329 (≈85.86%).
  • Reverse split approval vote: For 52,697,618; Against 1,559,976; Abstain 29,735.
  • Authorized shares increase vote: For 42,687,545; Against 11,570,307; Abstain 29,477. Certificate of Amendment dated May 28, 2026 was filed.
  • Auditor ratification vote: For 54,274,675; Against 5,234; Abstain 7,420. Director election votes: Bruce Steel — For 45,955,052; Charles McDermott — For 36,072,238.

Why It Matters

  • The reverse split authorization gives the Board flexibility to consolidate shares (between 1-for-2 and 1-for-20), which can affect share count and per-share metrics and is often used to raise the per-share stock price. Implementation is discretionary and not automatic.
  • Increasing authorized shares to 400 million expands the company’s ability to issue additional equity for financing, acquisitions, employee plans, or other corporate purposes, which could dilute existing holders if new shares are issued.
  • Board composition changed (one director not renominated and total seats reduced) and the auditor was ratified—both governance items investors watch for continuity and oversight.

Loading document...